<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ACETOHEXAMIDE</span><br/>(a-seat-oh-hex'a-mide)<br/><span class="topboxtradename">Dimelor <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">hormone and synthetic substitute</span>; <span class="classification">sulfonylurea antidiabetic agents</span><br/><b>Prototype: </b>Glyburide<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Lowers blood glucose by stimulating pancreatic beta cells to secrete insulin.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>More potent and has longer action than tolbutamide. Promotes increased effectiveness of endogenous insulin.</p>
<h1><a name="uses">Uses</a></h1>
<p>Mild to moderately severe stable type 2 diabetes mellitus. Preferred by some clinicians for patients who also have gout.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to sulfonylureas; severe impairment of hepatic, renal, thyroid, or other endocrine function; as sole therapy
         for type 1 diabetes mellitus and in diabetes complicated by ketosis, acidosis, coma, infection, trauma, hyperglycemia, and
         glycosuria associated with primary renal disease. Safety during pregnancy (category C), lactation, or in children is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Renal insufficiency, hepatic impairment, history of hepatic porphyria.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Diabetes</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250 mg/d before breakfast, may be increased by 250500 mg q57d (max: 1.5 g/d); may be dosed b.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Administer daily dose before breakfast.</li>
<li>Divided doses are given before breakfast and dinner.</li>
<li>Store at 15°30° C (59°86° F), unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Generally dose-related. Erythema, urticaria, pruritus, rash, photosensitivity. <span class="typehead">GI:</span> Nausea, vomiting, epigastric fullness, anorexia, stomach pain or discomfort, heartburn, diarrhea. <span class="typehead">Hematologic:</span>
<span class="speceff-life">Agranulocytosis, aplastic anemia, severe hypoglycemia</span>, thrombocytopenia. <span class="typehead">CNS:</span> Headache, dizziness. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>
<span class="alt">Serum uric acid</span> levels may be appreciably reduced.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol</b> may elicit <b>disulfiram</b> reaction; <b>warfarin,</b>
<b>aspirin</b> and other <span class="classification">salicylates</span>, <b>chloramphenicol,</b>
<b>clofibrate,</b>
<b>fenfluramine,</b>
<b>guanethidine,</b>
<span class="classification">mao inhibitors</span>, <b>oxytetracycline,</b>
<b>phenylbutazone,</b>
<b>probenecid,</b>
<b>sulfinpyrazone,</b> and <span class="classification">sulfonamides</span> may enhance hypoglycemic effects; with <b>diazoxide</b> there is mutual antagonism and effects of both drugs are reduced; <span class="classification">thiazide diuretics</span> may exacerbate hyperglycemia, resulting in need for increased acetohexamide doses; <b>phenytoin</b> may decrease effects of acetohexamide; <span class="classification">beta-adrenergic blockers</span> may mask symptoms of hypoglycemia. <span class="typehead">Herbal:</span>
<b>Garlic,</b>
<b>ginseng</b> may increase hypoglycemic effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract. <span class="typehead">Onset:</span> 1 h. <span class="typehead">Peak:</span> 24 h. <span class="typehead">Duration:</span> 1224 h. <span class="typehead">Distribution:</span> Breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver to active metabolite. <span class="typehead">Elimination:</span> 8095% eliminated in urine; 15% in bile. <span class="typehead">Half-Life:</span> 56 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor blood glucose levels closely during first 2448 h after therapy is initiated or the dose is changed.</li>
<li>Monitor for S&amp;S of hypoglycemia/exaggerated hypoglycemic response, particularly in older adults, malnourished, and debilitated
            patients or those with impaired hepatic, renal function, adrenal, or pituitary insufficiency.
         </li>
<li>Lab tests: Periodic blood glucose, hemoglobin A<sub>1-C</sub>, and liver functions.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Ingest some form of sugar (e.g., orange juice, dissolved table sugar, corn syrup, honey) if symptoms of hypoglycemia develop,
            and seek medical assistance.
         </li>
<li>Check blood glucose as prescribed.</li>
<li>Do not take any other medication unless approved by physician.</li>
<li>Alcoholic beverages may produce a disulfiram-type reaction (see Appendix F).</li>
<li>Avoid prolonged direct exposure to sun to prevent photosensitivity reaction.</li>
<li>Report dermatologic reactions such as rash or itching.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>